Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
SYNTHEKINE
Synthekine

Synthekine competitors

Company

Synthekine has 6 close competitors: ABC Supply, AliveCor, Attentive.

ProfileValuationFundingCompetitorsStock & IPOHow to invest
Peer set

Who competes with Synthekine

Sector, valuation and status for each competitor.

company profileSynthekine›
competitorABC Supply›
$15Blatest valuation
Founded 1973Private
competitorAliveCor›
$467.2Mas of Aug 2022
Founded 2011Private
competitorAttentive›
$7Bas of Jun 2021
Founded 2018Private
competitorCafe Coffee Day›
$340Mlatest valuation
Founded 1993Public
competitorCambly›
$250Mas of Jun 2022
competitorCarbon Health›
$1.4Blatest valuation
Founded 2015Private
Head-to-head

Synthekine and its peers, side by side

A private valuation and a public market cap share one column; each row names its basis and date.

Company
Sector
Founded
Valuation / market cap
Status
HQ
On Canborsa
SSynthekine
no figure
Company profile
ABC Supply
Building Products Distribution
1973
$15B
PRIVATE
United States
Company profile
AliveCor
2011
$467.2MAug 2022
PRIVATE
United States
Company profile
Attentive
Mobile Marketing
2018
$7BJun 2021
PRIVATE
United States
Company profile
Cafe Coffee Day
1993
$340M
PUBLIC
IN
Company profile
Cambly
$250MJun 2022
United States
Company profile
Carbon Health
Primary healthcare
2015
$1.4B
PRIVATE
United States
Company profile
Context · reading the peer set

Where Synthekine meets its rivals

What Synthekine sells, and where the rivals meet it

- Careers

Synthekine competes with 6 companies here: ABC Supply, AliveCor, Attentive, Cafe Coffee Day, Cambly, Carbon Health.

Synthekine on Canborsa
MarketClosest: SP500-PERP
Fees0.07% per side · 0.14% round-trip
Fundingevery 1h

Synthekine competitors — frequently asked questions

What is Synthekine?›

Synthekine is a biotechnology company that applies protein engineering platforms to develop cytokine therapeutics for cancer and autoimmune disease, aiming to unlock the efficacy of cytokines while avoiding the toxicity that comes from their pleiotropic effects on the immune system.

How much money has Synthekine raised in total?›

Synthekine's total funding stands at $289.5M over 3 rounds.

What's the most recent round for Synthekine?›

Synthekine's most recent round was Series B, raising $107.5M in June 2021.

Which investors back Synthekine?›

Synthekine's lead investors include Deerfield Management and Janus Henderson Investors.

Keep exploring
More companies
Helion Energy competitorscompetitors›Hello (formerly Hellobike / Hello Chuxing) valuationvaluation›Heimdall Power profilecompany · profile›Hellobike profilecompany · profile›All companiesdirectory›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
Cerebras Systems (CBRS)US equity · perp›ChangXin Memory Technologies (CXMT)Asian equity · perp›SpaceX (SPCX)US equity · perp›Alphabet (GOOGL)US equity · perp›All 86 marketsindex›
Index · Perpetual · 30x

Trade SP500-PERP on Canborsa

S&P 500 · the Canborsa market closest to Synthekine
SpaceXAnthropicTailscaleSwitchTekeverAll companies ›
© Canborsa 2026TermsPrivacy